Browse by author
Lookup NU author(s): Dr Henrique De Paula LemosORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Several studies have pointed out the immunomodulatory properties of the Salivary Gland Extract (SGE) from Lutzomyia longipalpis. We aimed to identify the SGE component (s) responsible for its effect on ovalbumin (OVA)-induced neutrophil migration (NM) and to evaluate the effect of SGE and components in the antigen-induced arthritis (AIA) model. We tested the anti-arthritic activities of SGE and the recombinant LJM111 salivary protein (rLJM111) by measuring the mechanical hypernociception and the NM into synovial cavity. Furthermore, we measured IL-17, TNF-α and IFN-γ released by lymph nodes cells stimulated with mBSA or anti-CD3 using enzyme-linked immunosorbent assay (ELISA). Additionally, we tested the effect of SGE and rLJM111 on co-stimulatory molecules expression (MHC-II and CD-86) by flow cytometry, TNF-α and IL-10 production (ELISA) of bone marrow-derived dendritic cells (BMDCs) stimulated with LPS, chemotaxis and actin polymerization from neutrophils. Besides, the effect of SGE on CXCR2 and GRK-2 expression on neutrophils was investigated. We identified one plasmid expressing the protein LJM111 that prevented NM in OVA-challenged immunized mice. Furthermore, both SGE and rLJM111 inhibited NM and pain sensitivity in AIA and reduced IL-17, TNF-α and IFN-γ. SGE and rLJM111 also reduced MHC-II and CD-86 expression and TNF-α whereas increased IL-10 release by LPS-stimulated BMDCs. SGE, but not LJM 111, inhibited neutrophils chemotaxis and actin polymerization. Additionally, SGE reduced neutrophil CXCR2 expression and increased GRK-2. Thus, rLJM111 is partially responsible for SGE mechanisms by diminishing DC function and maturation but not chemoattraction of neutrophils.
Author(s): Grespan R, Lemos HP, Carregaro V, Verri WAJr, Souto FO, deOliveira CJ, Teixeira C, Ribeiro JM, Valenzuela JG, Cunha FQ
Publication type: Article
Publication status: Published
Journal: International Immunopharmacology
Year: 2012
Volume: 12
Issue: 4
Pages: 603-610
Print publication date: 01/04/2012
Online publication date: 21/02/2012
ISSN (print): 1567-5769
ISSN (electronic): 1878-1705
Publisher: Elsevier
URL: http://doi.org/10.1016/j.intimp.2012.02.004
DOI: 10.1016/j.intimp.2012.02.004
PubMed id: 22366405
Altmetrics provided by Altmetric